Anti-biofilm and resistance suppression activities of CXA-101 against chronic respiratory infection phenotypes of Pseudomonas aeruginosa strain PAO1.

Anti-biofilm and resistance suppression activities of CXA-101 against chronic respiratory infection phenotypes of Pseudomonas aeruginosa strain PAO1.

Item
http://www.wikidata.org/entity/Q43077048
Dynamics of mutator and antibiotic-resistant populations in a pharmacokinetic/pharmacodynamic model of Pseudomonas aeruginosa biofilm treatment.Inhibition of bacterial biofilm formation and swarming motility by a small synthetic cationic peptideCeftolozane/tazobactam: a novel cephalosporin/β-lactamase inhibitor combination with activity against multidrug-resistant gram-negative bacilli.Pan-β-lactam resistance development in Pseudomonas aeruginosa clinical strains: molecular mechanisms, penicillin-binding protein profiles, and binding affinities.Combinatorial Pharmacodynamics of Ceftolozane-Tazobactam against Genotypically Defined β-Lactamase-Producing Escherichia coli: Insights into the Pharmacokinetics/Pharmacodynamics of β-Lactam-β-Lactamase Inhibitor Combinations.Ceftolozane/tazobactam (CXA 201) for the treatment of intra-abdominal infections.The problems of antibiotic resistance in cystic fibrosis and solutions.Ceftolozane/Tazobactam: A Review in Complicated Intra-Abdominal and Urinary Tract Infections.Antimicrobial Pressure of Ciprofloxacin and Gentamicin on Biofilm Development by an Endoscope-Isolated Pseudomonas aeruginosa.In vitro Activity of Ceftolozane/Tazobactam Alone or with an Aminoglycoside Against Multi-Drug-Resistant Pseudomonas aeruginosa from Pediatric Cystic Fibrosis Patients.Quercetin is an effective inhibitor of quorum sensing, biofilm formation and virulence factors in Pseudomonas aeruginosa.Pseudomonas aeruginosa ceftolozane-tazobactam resistance development requires multiple mutations leading to overexpression and structural modification of AmpCAffinity of the new cephalosporin CXA-101 to penicillin-binding proteins of Pseudomonas aeruginosa.Time-Kill Analysis of Ceftolozane/Tazobactam Efficacy Against Mucoid Pseudomonas aeruginosa Strains from Cystic Fibrosis Patients.
P2860

Anti-biofilm and resistance suppression activities of CXA-101 against chronic respiratory infection phenotypes of Pseudomonas aeruginosa strain PAO1.

Item
http://www.wikidata.org/entity/Q43077048
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
Anti-biofilm and resistance su ...... omonas aeruginosa strain PAO1.
@en
Anti-biofilm and resistance su ...... omonas aeruginosa strain PAO1.
@nl
type
label
Anti-biofilm and resistance su ...... omonas aeruginosa strain PAO1.
@en
Anti-biofilm and resistance su ...... omonas aeruginosa strain PAO1.
@nl
prefLabel
Anti-biofilm and resistance su ...... omonas aeruginosa strain PAO1.
@en
Anti-biofilm and resistance su ...... omonas aeruginosa strain PAO1.
@nl
P1433
P1476
P2093
P304
P31
P356
P407
P433
P478
P577
P5875
P698
P921
P356
P1433
P1476
Anti-biofilm and resistance su ...... omonas aeruginosa strain PAO1.
@en
P2093
P304
P31
P356
P407
P433
P478
P577
P5875
P698
P921